Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure
Clinical trial NCT07085728 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07085728
- Sponsor
- Eastern Cooperative Oncology Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-11
- Primary completion
- 2027-02-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.